Back to Search

MARK FLEISHER, MD

MD

Psychiatry Physician

NPI: 1568410322Individual

Specialties, Licenses & Credentials

Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

17803(NE)

Research & Publications (20)

Criteria for tumor marker evaluation and utilization.
PMID 12705209·MLO Med Lab Obs·2003
8-other
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
PMID 19652067·J Clin Oncol·2009
3-trial
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.
PMID 19604241·Br J Haematol·2009
8-other
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
PMID 19233911·Clin Chem·2009
8-other
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
PMID 19474785·Clin Pharmacol Ther·2009
8-other
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.
PMID 19608765·Genes Dev·2009
7-preclinical
Bone disease in thalassemia: a frequent and still unresolved problem.
PMID 18505376·J Bone Miner Res·2009
8-other
A multiplex assay for detecting genetic variations in CYP2C9, VKORC1, and GGCX involved in warfarin metabolism.
PMID 19233910·Clin Chem·2009
8-other
Determination of busulfan in human plasma using an ELISA format.
PMID 19494794·Ther Drug Monit·2009
8-other
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.
PMID 19213602·Lancet Oncol·2009
8-other
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
PMID 19003994·Int J Cancer·2009
8-other
Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling.
PMID 18958454·Anal Bioanal Chem·2009
8-other
Detection of circulating tumor cells in patients with urothelial cancer.
PMID 18836088·Ann Oncol·2009
8-other
Wind-driven upwelling in the Southern Ocean and the deglacial rise in atmospheric CO2.
PMID 19286547·Science·2009
8-other
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.
PMID 19276271·Clin Cancer Res·2009
8-other
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.
PMID 18413378·J Nucl Med·2008
4-observational
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
PMID 18565882·J Clin Oncol·2008
3-trial
A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.
PMID 18706417·Gastroenterology·2008
2-rct
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.
PMID 18724361·Nature·2008
7-preclinical
Further evidence for the validity of assessment center dimensions: a meta-analysis of the incremental criterion-related validity of dimension ratings.
PMID 18808224·J Appl Psychol·2008
1-meta

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
988102 NEBRASKA MEDICAL CTR
OMAHA, NE 68198

Location

Practice Location

988102 NEBRASKA MEDICAL CTR, OMAHA, NE
(402) 552-6007

Quick Facts

NPI
1568410322
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile